Clinical Trials in Los Angeles

Showing 4241-4260 of 12,794 trials

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

NCT04851691

The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each participating clinician's pill days per patient prescribed.

Alzheimer DiseaseDementia AlzheimersDementia of Alzheimer Type

University of California, Los Angeles158 participantsStarted Aug 2021

Los Angeles, California, United States

COMPLETEDNA< 1 mile

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

NCT03583099

A prospective, multicenter study including a cross-section validation to define sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant Chronic Obstructive Pulmonary Disease (COPD), and its impact on clinical care across a broad range of primary care settings in a cluster randomized controlled clinical trial.

Chronic Obstructive Pulmonary Disease (COPD)

Weill Medical College of Cornell University2,004 participantsStarted Oct 2018

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +6 more locations

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Find Trials by Condition in Los Angeles

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

A Safety and Efficacy Study in Patients With Gastric Cancer

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Breast Cancer Index (BCI) Registry

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Clinical Evaluation of the i-STAT TBI Test

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Pilot Trial of the RUBI Program for Autistic Adults